| For: | Jacobs NR, Norton PA. Role of chromosome 1q copy number variation in hepatocellular carcinoma. World J Hepatol 2021; 13(6): 662-672 [PMID: 34239701 DOI: 10.4254/wjh.v13.i6.662] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v13/i6/662.htm |
| Number | Citing Articles |
| 1 |
Moeko Minakuchi, Haoran Zhang, Joel Cassel, Yusuke Shiromoto, Jessie Villanueva, Emmanuel Skordalakes, Joseph M. Salvino, Qin Li, Kazuko Nishikura. Identification of ADAR1i-124: The first effective A-to-I RNA editing inhibitor with promising cancer therapeutic potential. iScience 2026; 29(2): 114615 doi: 10.1016/j.isci.2025.114615
|
| 2 |
Luxi Yang, Zhonghong Xiong, Jing Yang, Jingsong Mei, Jinsen Wei, Yali Liu, Yumin Li. Research Report on NUF2-Targeted Therapy for Digestive System Cancers: from Mechanism to Clinical Translation. Current Oncology Reports 2026; 28(1) doi: 10.1007/s11912-026-01743-0
|
| 3 |
Yi Chen, Mengjia Huang, Junkai Zhu, Li Xu, Wenxuan Cheng, Xiaofan Lu, Fangrong Yan. Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.857060
|
